SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-24-017682
Filing Date
2024-04-03
Accepted
2024-04-03 18:00:43
Documents
2
Period of Report
2023-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 9382
2 EXHIBIT 99.1 ef20025809_ex99-1.htm EX-99.1 12259
  Complete submission text file 0001140361-24-017682.txt   24097
Mailing Address DR LUIS BONAVITA 1294 OFFICE 2004 MONTEVIDEO X3 11300
Business Address DR LUIS BONAVITA 1294 OFFICE 2004 MONTEVIDEO X3 11300 982-626-2344
KNIGHT THERAPEUTICS INTERNATIONAL SA (Reporting) CIK: 0001632373 (see all company filings)

State of Incorp.: X3 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41719 | Film No.: 24820539

Mailing Address 3400 BOULEVARD DE MAISONNEUVE WEST SUITE 1055 MONTREAL A8 H3Z 3B8
Business Address 3400 BOULEVARD DE MAISONNEUVE WEST SUITE 1055 MONTREAL A8 H3Z 3B8 5144844483
Knight Therapeutics Inc (Reporting) CIK: 0001756235 (see all company filings)

State of Incorp.: A8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41719 | Film No.: 24820540

Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Issuer) CIK: 0001946563 (see all company filings)

IRS No.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)